Table 1.

Patient demographics by category.

Category Variables	Total	Normal	High	p Value
Number of cases	205	154	51	NA
Gender: Female	46.3%	48.1%	41.2%	0.394
Gender: Male	53.7%	51.9%	58.8%
AHD ≥ 2 Mo: Yes	31.2%	31.2%	31.4%	0.95
Prior Malignancy: Yes	16.6%	14.9%	21.6%	0.3
Prior Chemo: Yes	8.8%	7.8%	11.8%	0.41
Prior XRT: Yes	8.3%	5.8%	15.7%	0.027
Infection: Yes	27.8%	26.0%	33.3%	0.35
WHO Class: Not in other	60.5%	60.4%	60.8%	0.72
WHO class: Multilineage Dysp	15.6%	14.3%	19.6%
WHO Class: therapy related	8.3%	9.1%	5.9%
WHO Class: AML w Char Gene Abnormality	15.6%	16.2%	13.7%
FAB: 0	5.9%	7.1%	2.0%	< 0.0001
FAB: 1	12.7%	16.2%	2.0%
FAB: 2	33.2%	39.6%	13.7%
FAB: 4	28.3%	24.0%	41.2%
FAB: 5	12.2%	6.5%	29.4%
FAB: 6	2.0%	1.3%	3.9%
FAB: 7	2.4%	2.6%	2.0%
FAB: 8	2.9%	2.6%	3.9%
FAB: 10	0.5%	0.0%	2.0%
Cytogenetics: Favorable	10.7%	13.6%	2.0%	0.06
Cytogenetics: Intermediate	46.3%	45.5%	49.0%
Cytogenetics: Unfavorable	42.9%	40.9%	49.0%
Response: CR	57.6%	55.8%	62.7%	0.31 for CR + PR vs resistant and excluding Fail
Response: PR	2.4%	3.2%	0.0%
Response: Resistant	30.2%	32.5%	23.5%
Response: Fail	9.8%	8.4%	13.7%
Alive	19.0%	21.4%	11.8%	0.11
Relapse: No	42.4%	48.8%	25.0%	0.036
Relapse: Yes	61.9%	57.0%	75.0%